Overall rank by patents
#542
Across all tracked assignees
USPTO PatentsView assignee record - 825 granted patents across 73 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Shanghai holds 825 US patents across 73 technology areas, rank #542 of 50,000 tracked assignees.
Shanghai United Imaging Healthcare Co., Ltd. has been granted 825 US utility patents between 2016 and 2025, placing Shanghai United Imaging Healthcare Co., Ltd. at rank #542 across all assignees tracked by PlainPatent. This portfolio spans 73 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.9 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Shanghai United Imaging Healthcare Co., Ltd. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Shanghai sits between The Gillette Company Llc (830 patents, rank #538) and Industry-academic Cooperation Foundation, Yonsei University (823 patents, rank #546) - the closest US assignees by grant volume. The composite Innovation Score of 69.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 731 grants, compared with 94 in the 2015–2019 window, a +678% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Shanghai United Imaging Healthcare Co., Ltd.'s 18.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 73 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Shanghai United Imaging Healthcare Co., Ltd. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
The Gillette Company LLC
830 patents
CORNING OPTICAL COMMUNICATIONS LLC
828 patents
STMicroelectronics (Rousset) SAS
828 patents
University of Massachusetts
828 patents
Silicon Laboratories Inc.
825 patents
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.
825 patents
E Ink Holdings Inc.
824 patents
KANEKA CORPORATION
824 patents
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
823 patents
What this shows Shanghai holds 825 patents at rank #542, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #542 in granted patent volume.
Other assignees with the most granted patents in Shanghai's primary technology class.
Shanghai's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
69 Top 1% higher than 99% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 7 | 0.8% |
| 2017 | 10 | 1.2% |
| 2018 | 14 | 1.7% |
| 2019 | 63 | 7.6% |
| 2020 | 113 | 13.7% |
| 2021 | 112 | 13.6% |
| 2022 | 129 | 15.6% |
| 2023 | 145 | 17.6% |
| 2024 | 136 | 16.5% |
| 2025 | 96 | 11.6% |
Top 15 of 73 technology areas
Overall rank by patents
#542
Across all tracked assignees
69.0 out of 100
How to use this portfolio
Shanghai's 825 grants land it in the top 1% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.